AbbVie, Inc. (ABBV)
223.03
-4.20
(-1.85%)
USD |
NYSE |
Jun 08, 16:00
223.07
+0.04
(+0.02%)
After-Hours: 18:38
AbbVie EPS Diluted (Quarterly) : 0.3861 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.612 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Travere Therapeutics, Inc. | -0.3984 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 687.00M |
| Revenue (Quarterly) | 15.00B |
| Total Expenses (Quarterly) | 14.32B |
| Enterprise Value | 464.97B |
| Gross Profit Margin (Quarterly) | 71.93% |
| Profit Margin (Quarterly) | 4.58% |
| Earnings Yield | 0.91% |
| Operating Earnings Yield | 5.33% |
| Normalized Earnings Yield | 3.281 |